JW Lifescience Corporation (234080.KS)

KRW 11520.0

(-0.78%)

Long Term Debt Summary of JW Lifescience Corporation

  • JW Lifescience Corporation's latest annual long term debt in 2023 was 168 Million KRW , down -99.44% from previous year.
  • JW Lifescience Corporation's latest quarterly long term debt in 2024 Q2 was 30.14 Billion KRW , up 35787.67% from previous quarter.
  • JW Lifescience Corporation reported annual long term debt of 30.04 Billion KRW in 2022, up 1730.01% from previous year.
  • JW Lifescience Corporation reported annual long term debt of 1.64 Billion KRW in 2021, up 4.4% from previous year.
  • JW Lifescience Corporation reported quarterly long term debt of 84 Million KRW for 2024 Q1, down -50.0% from previous quarter.
  • JW Lifescience Corporation reported quarterly long term debt of 168 Million KRW for 2023 Q4, down -54.19% from previous quarter.

Annual Long Term Debt Chart of JW Lifescience Corporation (2023 - 2011)

Historical Annual Long Term Debt of JW Lifescience Corporation (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 168 Million KRW -99.44%
2022 30.04 Billion KRW 1730.01%
2021 1.64 Billion KRW 4.4%
2020 1.57 Billion KRW -71.23%
2019 5.46 Billion KRW -47.58%
2018 10.42 Billion KRW -32.4%
2017 15.42 Billion KRW 9.93%
2016 14.03 Billion KRW 66.81%
2015 8.41 Billion KRW 221.15%
2014 2.62 Billion KRW 0.0%
2013 - KRW -100.0%
2012 10.59 Billion KRW -26.55%
2011 14.43 Billion KRW 0.0%

Peer Long Term Debt Comparison of JW Lifescience Corporation

Name Long Term Debt Long Term Debt Difference
Yuyu Pharma, Inc. 13.64 Billion KRW 98.768%
Dong-A Socio Holdings Co., Ltd. 202.06 Billion KRW 99.917%
Ildong Holdings Co., Ltd. 29.87 Billion KRW 99.438%
HANDOK Inc. 123.78 Billion KRW 99.864%
Kukje Pharma Co., Ltd. 475.74 Million KRW 64.687%
Yuhan Corporation 60.23 Billion KRW 99.721%
Dong-A ST Co., Ltd. 161.99 Billion KRW 99.896%
SAMSUNG PHARM. Co., LTD. 101.81 Million KRW -65.001%
Hanmi Pharm. Co., Ltd. 82.02 Billion KRW 99.795%
Hanall Biopharma Co.,Ltd 590.3 Million KRW 71.54%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW 97.223%
Dong Sung Bio Pharm.Co.,Ltd. 18.52 Billion KRW 99.093%
MYUNGMOON Pharm co.,Ltd 12.58 Billion KRW 98.665%
Hana Pharm Co., Ltd. 1.59 Billion KRW 89.492%
Yuyu Pharma, Inc. 13.64 Billion KRW 98.768%
Ilsung Pharmaceuticals Co., Ltd. 119.67 Million KRW -40.376%
REYON Pharmaceutical Co., Ltd. 121 Billion KRW 99.861%
Aprogen pharmaceuticals,Inc. 32 Billion KRW 99.475%
JW Holdings Corporation 20.65 Billion KRW 99.187%
Ildong Pharmaceutical Co., Ltd. 14.82 Billion KRW 98.867%
Chong Kun Dang Pharmaceutical Corp. 30 Billion KRW 99.44%
JW Pharmaceutical Corporation 30 Billion KRW 99.44%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW 23.274%
Hyundai Pharmaceutical Co., Ltd. 580.64 Million KRW 71.067%
Samil Pharmaceutical Co.,Ltd 49.56 Billion KRW 99.661%
Jeil Pharmaceutical Co.,Ltd 4.45 Billion KRW 96.226%
Yuyu Pharma, Inc. 13.64 Billion KRW 98.768%
Kwang Dong Pharmaceutical Co., Ltd. 19.02 Billion KRW 99.117%
Daewoong pharmaceutical Co.,Ltd 93.41 Billion KRW 99.82%
JW Pharmaceutical Corporation 30 Billion KRW 99.44%
Yuhan Corporation 60.23 Billion KRW 99.721%
Jeil Pharma Holdings Inc 10.5 Billion KRW 98.4%
Yungjin Pharm. Co., Ltd. 40.37 Billion KRW 99.584%
Suheung Co., Ltd. 74 Billion KRW 99.773%
JW Pharmaceutical Corporation 30 Billion KRW 99.44%
Samjin Pharmaceuticals Co., Ltd. 4.16 Billion KRW 95.968%
Korea United Pharm Inc. 10.96 Billion KRW 98.468%
CKD Bio Corp. 69.43 Billion KRW 99.758%
Daewon Pharmaceutical Co., Ltd. 34.57 Billion KRW 99.514%
Dongwha Pharm.Co.,Ltd 16.12 Billion KRW 98.958%
Whan In Pharm Co.,Ltd. 307.05 Million KRW 45.287%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW 23.274%
Chong Kun Dang Holdings Corp. 72.11 Billion KRW 99.767%
Boryung Corporation 151.7 Billion KRW 99.889%
Bukwang Pharmaceutical Co., Ltd. 78.52 Billion KRW 99.786%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW 97.223%